Is the Galleri multi-cancer blood test worth it? A doctor explains real-world performance data and explains why no major ...

Although not as essential as in other tumor types, genomic testing is increasingly playing a role in guiding treatment for advanced sarcoma.

EB103 utilizes Eureka’s ARTEMIS technology, a platform designed to harness the human immune system more effectively than standard therapies. The ARTEMIS T cells are engineered to address the specific ...

Acting as a crucial interface, or bridge between the Van Gogh’s camera and its PC, is a BitFlow Cyton CXP4 CoaXPress 1.1 ...

Driven by rising cancer prevalence, rapid adoption of liquid biopsies, and breakthroughs in single-cell analysis, the global ...

This results in liquid biopsy to be potentially less expensive as compared to surgical biopsies. Currently, there are several liquid biopsies in development for oncology. These technological ...

In addition, rise in funding for breast liquid biopsy R&D, favorable initiatives undertaken by governments and global health organizations, and increase in breast cancer liquid biopsy reagents ...

Cancer Dx expansion and inVue Dx FNA combine preventive screening and rapid, in-clinic diagnosis, enabling veterinarians and pet owners to act with confidence WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX ...

A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor cells circulating in the blood indicates whether a patient with lung cancer ...

Researchers have identified chromosomal instability in circulating tumour cells as a prognostic and predictive biomarker in metastatic castration resistant prostate cancer, using data from the phase 4 ...